ClearPoint Neuro (NASDAQ:CLPT) announces partnership with San Diego-based D&K Engineering for the continued development of a robotic system for use in both the MRI Suite and the Operating Room.

ClearPoint neuroo(纳斯达克代码:CLPT)日前宣布与圣地亚哥D&K工程公司合作，继续开发一种用于MRI和手术室的机器人系统。

The company expects first clinical use of the robotic assisted system in 2023.

该公司预计该机器人辅助系统的首次临床应用将在2023年。

“We are 100% behind the ambition and dedication of ClearPoint to help treat some of the most devastating neurological disorders imaginable. We all know family and friends afflicted with these diseases, and our team at D&K understands what is at stake. We are proud to offer our experience, our time and our energy to this important partnership.” commented Alex Kunczynski, President at D&K Engineering.

“我们100%支持ClearPoint的雄心和奉献精神，帮助治疗一些最具毁灭性的神经系统疾病。我们都知道家人和朋友受到这些疾病的折磨，我们在D&K的团队知道什么是利害攸关的。我们自豪地为这一重要的伙伴关系提供我们的经验、时间和精力。D&K工程公司总裁Alex Kunczynski评论道。